401 related articles for article (PubMed ID: 33081024)
1. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome.
Pietrobono D; Giacomelli C; Marchetti L; Martini C; Trincavelli ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081024
[TBL] [Abstract][Full Text] [Related]
2. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
3. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5.
Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J
Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040
[TBL] [Abstract][Full Text] [Related]
4. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T
Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030
[TBL] [Abstract][Full Text] [Related]
6. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
[TBL] [Abstract][Full Text] [Related]
7. Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro.
Iser IC; Ceschini SM; Onzi GR; Bertoni AP; Lenz G; Wink MR
Mol Neurobiol; 2016 Dec; 53(10):7184-7199. PubMed ID: 26687184
[TBL] [Abstract][Full Text] [Related]
8. A Bifunctional Molecule with Lectin and Protease Inhibitor Activities Isolated from
Bonturi CR; Silva MCC; Motaln H; Salu BR; Ferreira RDS; Batista FP; Correia MTDS; Paiva PMG; Turnšek TL; Oliva MLV
Molecules; 2019 Jun; 24(11):. PubMed ID: 31167364
[TBL] [Abstract][Full Text] [Related]
9. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines.
Breznik B; Motaln H; Vittori M; Rotter A; Lah Turnšek T
Oncotarget; 2017 Apr; 8(15):25482-25499. PubMed ID: 28424417
[TBL] [Abstract][Full Text] [Related]
11. CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth.
Azambuja JH; Gelsleichter NE; Beckenkamp LR; Iser IC; Fernandes MC; Figueiró F; Battastini AMO; Scholl JN; de Oliveira FH; Spanevello RM; Sévigny J; Wink MR; Stefani MA; Teixeira HF; Braganhol E
Mol Neurobiol; 2019 May; 56(5):3260-3279. PubMed ID: 30117104
[TBL] [Abstract][Full Text] [Related]
12. Tropism of mesenchymal stem cell toward CD133
Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
14. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
Onzi GR; Ledur PF; Hainzenreder LD; Bertoni AP; Silva AO; Lenz G; Wink MR
Cytotherapy; 2016 Jul; 18(7):828-37. PubMed ID: 27210718
[TBL] [Abstract][Full Text] [Related]
16. Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors.
Bajetto A; Pattarozzi A; Corsaro A; Barbieri F; Daga A; Bosio A; Gatti M; Pisaturo V; Sirito R; Florio T
Front Cell Neurosci; 2017; 11():312. PubMed ID: 29081734
[TBL] [Abstract][Full Text] [Related]
17. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
[TBL] [Abstract][Full Text] [Related]
18. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
20. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]